| Trial | Updated / Type |
Status | Phase | Were Results Reported |
Reported Actual Enrollment |
(MeSH) Terms |
Why Stopped
Limitations And Caveats |
Annotator decisions |
|---|---|---|---|---|---|---|---|---|
| NCT00728091 2007-007941-10 Details | 2016-05-26 Interventional | 3 | 2 | Satavaptan Hyponatremia Inappropriate A… Syndrome | - - | |||
| NCT00602745 Details | 2016-05-26 Interventional | 3 | 61 | Fluorouracil Neoplasm Metast… Neoplasms Pancreatic Neop… Pancreatic Neop… | Following the termination of development and commercialization agreement for S-1 with Taiho
Pharmaceutical - | |||
| NCT00464061 2006-004942-18 Details | 2016-05-26 Interventional | 3 | 1847 | Volinanserin Diabetes Mellit… Diabetes Mellit… Sleep Initiatio… | Sponsor's decision due to absence of demonstration of efficacy of volinanserin in primary
insomnia with predominant sleep maintenance problems - | |||
| NCT00395239 Details | 2016-05-26 Interventional | 4 | 6 | Budesonide Asthma | This project will resume upon the completion of other research committments. - | |||
| NCT01833221 Details | 2016-05-25 Interventional | 4 | 10 | Lidocaine Facial Paralysi… Facies Paresis Facial Paresis | The study reach enough significance at the intermediary analysis - | |||
| NCT01118403 Details | 2016-05-24 Interventional | 4 | 0 | Ampicillin Sulbactam Sultamicillin Pneumonia Pneumonia, Vent… Ventilator Asso… | He could not be started due to lack of funds - | |||
| NCT00359437 2006-000132-27 Details | 2016-05-24 Interventional | 3 | 501 | Satavaptan Ascites Fibrosis Liver Cirrhosis Recurrence | - - | |||
| NCT00263042 2005-002942-20 Details | 2016-05-20 Interventional | 3 | [1 Refs] | 18695 | Rimonabant Cardiovascular … Cardiovascular … | Company decision taken in light of demands by certain national health authorities - | ||
| NCT00228176 2005-001612-49 Details | 2016-05-20 Interventional | 3 | [1 Refs] | 661 | Rimonabant Arteriosclerosi… Atherosclerosis Carotid Stenosi… Metabolic Syndr… Carotid Artery … Metabolic Syndr… Obesity | Company decision taken in light of demands by certain national health authorities - | ||
| NCT02630563 Details | 2016-05-19 Interventional | 2 | 9 | Cyclosporine Cyclosporins Mycophenolic Ac… Pediatric Liver… | Due to extremely slow recruitment, infrequent use of combination triple therapy (MMF,
cyclosporine, steroids), study was discontinued; Part 2 was not conducted. Part I of the study was terminated early with 9 participants enrolled (8 of which were evaluable for PK), and Part II of the study was not performed due to extremely slow recruitment and the infrequent use of the combination of triple therapy. | |||
| NCT00498485 Details | 2016-05-19 Interventional | 4 | 17 | Sodium Oxybate Fatigue Fatigue Syndrom… Syndrome Chronic Fatigue… | Withdrawal of support. Too few subjects to get any definitive data. Based on the preliminary data analysis done with available subjects, we infer that had we completed the study, we might have found a significant effect for drug treated over placebo treated subjects. | |||
| NCT00690456 2007-004833-40 Details | 2016-05-18 Interventional | 3 | 403 | Metformin Rimonabant Diabetes Mellit… Diabetes Mellit… | Company decision taken in light of demands by certain national health authorities - | |||
| NCT00577148 2007-003013-14 Details | 2016-05-18 Interventional | 3 | 89 | Rimonabant Fatty Liver Non-alcoholic F… | Company decision taken in light of demands by certain national health authorities - | |||
| NCT00576667 2007-003013-14 Details | 2016-05-18 Interventional | 3 | 165 | Rimonabant Fatty Liver Non-alcoholic F… | Company decision taken in light of demands by certain national health authorities - | |||
| NCT00366795 2006-000132-27 Details | 2016-05-18 Interventional | 3 | 241 | Satavaptan Ascites Fibrosis Liver Cirrhosis Recurrence | Study was terminated due to safety reason. - | |||
| NCT00325650 Details | 2016-05-18 Interventional | 3 | 2420 | Rimonabant Prediabetic Sta… | Company decision taken in light of demands by certain national health authorities - | |||
| NCT00754689 2008-002500-26 Details | 2016-05-17 Interventional | 3 | 0 | Metformin Rimonabant Diabetes Mellit… Diabetes Mellit… | Company decision taken in light of demands by certain national health authorities - | |||
| NCT01983566 2013-003967-74 Details | 2016-05-16 Interventional | 1 | 16 | Omeprazole Healthy | - As the study was discontinued prematurely, the results were incomplete. Due to this incomplete data the endpoint AUC(0-inf) was not evaluated,and only a limited number of the planned statistical analyses could be performed. | |||
| NCT00979121 Details | 2016-05-16 Interventional | 3 | 745 | Rosuvastatin Ca… Acute Lung Inju… Lung Injury Sepsis Toxemia | stopped for futility - | |||
| NCT00741715 Details | 2016-05-16 Interventional | 3 | 1736 | Atorvastatin Hypercholestero… | AVE5530 in hypercholesterolemia was stopped due to insufficient efficacy - |